公开(公告)号：US20240082203A1

公开(公告)日：2024-03-14

申请号：US18259964

申请日：2021-12-29

申请人： SHANGHAI HUILUN BIOLOGICAL TECHNOLOGY CO., LTD. ,  SHANGHAI HUILUN JIANGSU PHARMACEUTICAL CO., LTD.

发明人： Changjun LI ,  Wenhua LI ,  Jihong QIN ,  Huali LIU ,  Jinfeng LI ,  Xiangjiang NIE

IPC分类号： A61K31/235 ,  A61K9/00 ,  A61K47/02 ,  A61K47/26

CPC分类号： A61K31/235 ,  A61K9/0078 ,  A61K47/02 ,  A61K47/26

摘要： The present invention relates to a pharmaceutical composition for inhalation, comprising N-[2-[[[4-(2,2-dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-(S)-glycinate sodium or a hydrate thereof, a pH adjuster, an osmotic pressure adjuster, and optionally a surfactant. The pharmaceutical composition for inhalation of the present invention can improve drug stability. After being atomized by an inhalation atomizing device, inhalation droplets can maintain good uniformity.